These markers were used to characterize immune cells, including B cells, CD8+ T cells, M1/M2 macrophages, tumor-associated macrophages, monocytes, NK, neutrophils, and DCs in LIHC and LUSC. This evidence concerns the gene CD8A and neoplasm.